Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2010
03/02/2010US7670840 Micro-RNA expression abnormalities of pancreatic, endocrine and acinar tumors
03/02/2010US7670833 Employing micro-array format; for use on human tissues
03/02/2010US7670832 System for fluorescence monitoring
03/02/2010US7670831 Detects various target biomaterials that bind or react with the bioreceptors by precisely measuring directly or by electrochemical signals at large amounts in one step
03/02/2010US7670830 fungicides in wide ranges of temperature and pH; pure culture
03/02/2010US7670828 Expression vector comprising nucleotide sequences coding genes associated with alcohol fermentation; for generating transgenic saccharomyces; improving productivity and/or flavor of alcoholic beverages
03/02/2010US7670826 Belonging to subfamily of human immunoglobulin superfamily; isolated antibodies and nucleic acids; transformed host cells; modulating transendothelial migration of leukocytes; inflammation, tumors
03/02/2010US7670816 UDP-galactose:β-D-galactose-R 4-α-D-galactosyltransferase, α4gal-T1
03/02/2010US7670815 useful in in vitro enzymatic reactions of this enzyme and in recombinant host cells for the production of glycoproteins with more efficient and extensive glycosylation
03/02/2010US7670810 Methods and compositions for whole genome amplification and genotyping
03/02/2010US7670809 Using mutase as genetic engineering tool which generates modified polypeptides; proteomics and phenotype analysis
03/02/2010US7670803 decompose a glycoside having soyasapogenol B as an aglycone to produce soyasapogenol B; a polynucleotide encoding such a protein; soyasapogenol B can be obtained independently of the saponin content of, for example, a soybean extract; host is filamentous fungus belonging to genus Trichoderma
03/02/2010US7670801 Using immunoglobulins to isolate heterologous polypeptide fusion comprising viral coat sequences in adenoviral protein expression systems of plants, animals and bacteria
03/02/2010US7670797 evaluation carried out in three-dimensional tissue-engineered systems, where drug toxicity, metabolism, interaction and/or efficacy can be determined
03/02/2010US7670796 Metalloprotease assay
03/02/2010US7670795 Methods for assaying acetyl transferase or deacetylase activity
03/02/2010US7670794 Monitoring serum concentrations of hemoglobin A1c (HbA1c), inorganic phosphate, and glucose; diuretic
03/02/2010US7670793 Enumeration of CD4+ lymphocytes
03/02/2010US7670785 Drug screening for a compound that modulates the NF kappa B activity of a guanylate binding protein associated with rheumatoid arthritis
03/02/2010US7670780 Molecular biology; probe to given sequence; detection of this fungi in a sample
03/02/2010US7670779 Mixture comprising nucleotide triphosphates and nucleotide diphosphates which enhances nucleotide sequences replication; diagnosing infection
03/02/2010US7670778 Using malignant brain tumor (MBT) repeat protein (LIN-61) as tool in identifying modulators for prevention and treatment of cell proliferative disorders
03/02/2010US7670777 Method for detecting DNA methylation using labelled S-adenosylmethionine analogs
03/02/2010US7670776 MYH gene variants and use thereof
03/02/2010US7670775 Using phospholipase expression profile as diagnostic/predicitve tool in classifying tumor malignancy
03/02/2010US7670774 genotype analysis of HPV; predicting cervical cancer and precancerous lesion; can analyze the 40 types of HPV found in cervices, diagnose complex infection by at least one type of HPV, and have excellent diagnostic sensitivity and specificity on HPV genetic type
03/02/2010US7670773 detecting Rett syndrome, a neuropsychiatric disorder
03/02/2010US7670772 Immobilizing probes in a microfluidic channel using a polymer and having a blocking wall for preventing mixing of samples; photopolymerization of glycidyl methacrylate as probe immobilization region, and polyethylene glycol diacrylate as blocking wall material
03/02/2010US7670771 Assessing human predisposition to a febrile seizure disorder
03/02/2010US7670770 comprising surface having a plurality of channels having a trench width of less than about 150 nanometers and depth of less than 200 nanometers
03/02/2010US7670769 IL1RL-1 as a cardiovascular disease marker and therapeutic target
03/02/2010US7670768 Isolating DNA from cells using lysing reagent and RNA digesting enzyme on a solid support; purifying DNA from biological samples; e.g. from white blood cells in a whole blood sample; without the use of harmful organic solvents such as urea and guanidine-based solvents
03/02/2010US7670767 Genetic alterations associated with cancer
03/02/2010US7670766 Early detection of flaviviruses using the NS1 glycoprotein
03/02/2010US7670765 Method of forming monolayers of phage-derived products and used thereof
03/02/2010US7670764 Methods of diagnosing tissue fibrosis
03/02/2010US7670763 determining sperm quality, and different storage media's effect thereon; male fertility
03/02/2010US7670605 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
03/02/2010US7670601 Using uterine tumor specific marker as diagnostic tool in detection of urogenital specific cell proliferative disorders
03/02/2010US7670599 Using monoclonal antibody as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders; immunotherapy
03/02/2010US7670596 Multi-lineage progenitor cells
03/02/2010US7670556 Generation of solid supports; obtain thin film with grooves coated with substrate, expose to biopolymers, allow binding, remove thin film, recover microarray
03/02/2010US7670470 Biosensor membranes composed of polymers containing heterocyclic nitrogens
03/02/2010CA2390659C Ny-eso-1 peptide derivatives, and uses thereof
03/02/2010CA2268753C Nucleic acid primers and probes for detecting oncogenic human papillomaviruses
03/02/2010CA2190359C Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection
03/02/2010CA2140894C Modified fungal cells and method for producing recombinant products
02/2010
02/25/2010WO2010022398A1 Diagnosis and treatment of neuro-inflammatory disorders
02/25/2010WO2010022391A2 Integrated, automated system for the study of cell and tissue function
02/25/2010WO2010022332A1 Method for chromogenic detection of two or more target molecules in a single sample
02/25/2010WO2010022328A2 Genetic loci associated with head smut resistance in maize
02/25/2010WO2010022289A2 Methods for removal of specific seed tissue or structure for seed analysis
02/25/2010WO2010022281A1 Methods for using human neutrophil elastase as an indicator of active wound infection
02/25/2010WO2010022268A2 Markers for assessing the susceptibility of cancer to igf-1r treatment
02/25/2010WO2010022235A2 Genome-wide association study of autism reveals a comnon novel risk locus at 5p14.1
02/25/2010WO2010022211A1 Use of a cox-2 inhibitor for the treatment of a cox-2 dependent disorder in a patient not carrying hla alleles associated with hepatotoxicity
02/25/2010WO2010022202A1 Kinetic biologic activity assays and kinetic von willebrand assay
02/25/2010WO2010022166A2 Micro rna (mirna) and neurofibromatosis type 1 : a role in diagnosis and therapy
02/25/2010WO2010022111A1 Methods and compositions for enumerating antibiotic-resistant microorganisms
02/25/2010WO2010022098A2 Dna methylation detection methods
02/25/2010WO2010021872A2 Enhancing endotoxin detection
02/25/2010WO2010021870A1 A method for the analysis of o-linked oligosaccharides
02/25/2010WO2010021822A2 Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites
02/25/2010WO2010021696A1 Methods and compositions for determining a graft tolerant phenotype in a subject
02/25/2010WO2010021686A1 Luminogenic compounds and methods to detect cytochrome p450 3a enzymes
02/25/2010WO2010021534A1 Method for detecting and identifying candida species
02/25/2010WO2010021396A1 Method for quantification or detection of dna
02/25/2010WO2010021394A1 Method for quantification or detection of dna
02/25/2010WO2010021392A1 In vitro fluorescence observation method for mammal embryo, and method for selecting mammal embryo reduced in risk of implantation failure or abortion
02/25/2010WO2010021369A1 Method for detecting functional mold, method for evaluating functional mold-containing product and primer pair
02/25/2010WO2010021092A1 Method for testing on risk of metabolic syndrome or cardiovascular disease, and kit for risk test
02/25/2010WO2010020787A1 Diagnosis and treatment of tumours
02/25/2010WO2010020750A1 Method for the analysis of oligonucleotides
02/25/2010WO2010020695A1 Monosomy 1p36 syndrome
02/25/2010WO2010020694A1 Polynucleotides which down-regulate the expression of the sbi protein
02/25/2010WO2010020619A2 Susceptibility to dasatinib
02/25/2010WO2010020618A1 Susceptibility to hsp90-inhibitors
02/25/2010WO2010020590A1 Methods for predicting the response to anti-cancer treatment with an agonist of tlr7 or an agonist of tlr8
02/25/2010WO2010020589A1 Microfluidic device screening method
02/25/2010WO2010020252A1 Methods for determining a breeding value based on a plurality of genetic markers
02/25/2010WO2010020143A1 Genes, proteins and vectors for increaseing tolerance of plants and microbes to abiotic stresses and the use thereof
02/25/2010WO2010019995A1 The erg transcription factor modulation of vascular development
02/25/2010WO2010001212A3 Probes for use in diagnosing porphyria and allelic quantification of porphyria related genes by ligation and amplification reactions
02/25/2010WO2010001074A3 Novel detection probe
02/25/2010WO2009155061A8 Compositions for use in identification of strains of e. coli o157:h7
02/25/2010WO2009154966A3 Cleavable catalytic binding and detection system
02/25/2010WO2009153142A3 Microfluidic system
02/25/2010WO2009152928A3 Method for the quantitative analysis of nucleic acids, markers therefor and their use
02/25/2010WO2009151618A3 Methods and compositions for treating alzheimer's disease
02/25/2010WO2009150255A3 Markers for predicting response and survival in anti-egfr treated patients
02/25/2010WO2009150242A9 P2/p2a/p2b gene sequences as diagnostic targets for the identification of fungal and yeast species
02/25/2010WO2009149026A3 Genomic approaches to fetal treatment and diagnosis
02/25/2010WO2009146210A3 New human parvovirus: bocavirus
02/25/2010WO2009144424A3 Process and method for diagnosing alzheimer’s disease
02/25/2010WO2009143504A3 Methods of microrna detection and differentiation
02/25/2010WO2009143379A3 Use of extracellular rna to measure disease
02/25/2010WO2009143157A3 Self-assembly of nanoparticles through nucleic acid engineering
02/25/2010WO2009140550A3 Diagnosis of melanoma and solar lentigo by nucleic acid analysis
02/25/2010WO2009140198A3 Pathogen detection and screening
02/25/2010WO2009138499A3 Biomarkers for depression